Table 1.
Baseline characteristics | No. (%) |
---|---|
Sex | |
Male | 24 (83) |
Female | 5 (17) |
Age | |
Median (years) | 71 |
Range (years) | 57–88 |
pStage | |
I | 4 (14) |
II | 7 (24) |
III | 14 (48) |
IV | 4 (14) |
pT | |
1b | 2 (7) |
2 | 2 (7) |
3 | 14 (48) |
4a | 8 (28) |
4b | 3 (10) |
Histology | |
Intestinal | 15 (52) |
Diffuse | 11 (38) |
Mixed | 3 (10) |
Primary lesion location | |
Oesophagogastric junction | 2 (7) |
Upper | 9 (31) |
Middle | 7 (24) |
Lower | 11 (38) |
Macroscopic type (Borrmann) | |
1 (Mass) | 2 (7) |
2 (Ulcerative) | 13 (41) |
3 (Infiltrative ulcerative) | 11 (38) |
4 (Diffuse infiltrative) | 2 (7) |
5 (Unclassifiable) | 1 (3) |
HER2 status | |
Positive | 6 (21) |
Negative | 18 (62) |
Unknown | 5 (17) |
Helicobacter pylori infection | |
Positive | 20 (69) |
Negative | 9 (31) |
Surgical treatment | |
Total gastrectomy | 15 (52) |
Distal gastrectomy | 13 (45) |
Proximal gastrectomy | 1 (3) |
Tumor infiltrative (INF) pattern | |
INFa | 4 (3) |
INFb | 18 (62) |
INFc | 5 (17) |
Unknown | 2 (7) |
Lymphatic invasion (ly) | |
ly0 | 10 (34) |
ly1 | 5 (17) |
ly2 | 8 (28) |
ly3 | 5 (17) |
Unknown | 1 (3) |
Venous invasion (v) | |
v0 | 9 (31) |
v1 | 2 (7) |
v2 | 5 (17) |
v3 | 12 (41) |
Unknown | 1 (3) |